You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
Mallinckrodt
Boehringer Ingelheim
McKesson
Express Scripts

Last Updated: November 25, 2020

DrugPatentWatch Database Preview

Details for Patent: 7,608,616

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which drugs does patent 7,608,616 protect, and when does it expire?

Patent 7,608,616 protects DORAL and is included in one NDA.

Summary for Patent: 7,608,616
Title:Methods for reducing the risk of an adverse drug interaction in a patient suffering from insomnia
Abstract:Disclosed herein is a method for treating a patient with Quazepam that reduces the risk of an adverse interaction between the Quazepam and drug that is a substrate of the cytochrome P450 enzyme isoform 2B6 (CYP2B6 substrate drug), e.g., Bupropion. The method includes determining if the patient to be treated with Quazepam is being treated with a CYP2B6 substrate drug, and prescribing or treating the patient with Quazepam based on the determination.
Inventor(s): Cartt; Steve (Union City, CA)
Assignee: Questcor Pharmaceuticals, Inc. (Union City, CA)
Application Number:12/132,575
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 7,608,616

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Galt Pharms DORAL quazepam TABLET;ORAL 018708-003 Feb 26, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
Galt Pharms DORAL quazepam TABLET;ORAL 018708-001 Dec 27, 1985 RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
Merck
Express Scripts
AstraZeneca
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.